Validation of a Microlearning Approach to a Diabetes Prevention Program
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Stanford University
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Percent weight lost at 12 months from baseline weight
Study Overview
Brief Summary
The purpose of this study is to test the effectiveness of a mobile application diabetes prevention program delivered with microlearning and microcoaching.
Detailed Description
Patients with prediabetes who are interested in joining a diabetes prevention program will be randomized to either the mobile application diabetes prevention program or the traditional diabetes prevention program, which is delivered as a mixed program of in-person and virtual sessions.
Study participants in the mobile application version will download the Health U app from the Apple application store. The user will complete the daily microlearning modules and the health coach interactions within the Health U application. The 12-month diabetes prevention program will follow the widely clinically-validated CDC Get Active to Prevent T2 curriculum.
For participants participating in the in-person version, they will complete the diabetes prevention program, which meets in-person and virtually approximately once every two weeks.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 85 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •18 to 85 years old
- •high risk for type 2 diabetes (history of gestational diabetes, A1c 5.7-6.4)
Exclusion Criteria
- •non-English speaker
- •not comfortable using a mobile application
Arms & Interventions
Mobile application program
Intervention: Health U mobile application (Other)
Traditional program
Intervention: National Diabetes Prevention Program (Other)
Outcomes
Primary Outcomes
Percent weight lost at 12 months from baseline weight
Time Frame: 12 months
Secondary Outcomes
- change in hemoglobin A1c(12 months)
Investigators
Sandra Anping Tsai
Clinical Associate Professor
Stanford University